Folsom Metal Products recalled 10,960 units of 14 mm Distraction Pins on August 21, 2025. The recall follows concerns that the labeling included an unvalidated shelf life. Healthcare providers and patients must stop using the device immediately.
Labeling includes shelf life that has not been validated.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Folsom Metal Products, Inc. or your healthcare provider for instructions. Notification method: Letter
The recall involves Frontier Devices, REF: 301.914S1, 14 mm Distraction Pins, packaged in 10 single packs. These devices distributed nationwide in states including AL, CA, FL, GA, IL, MD, MI, PA, and TX.
The labeling of these distraction pins includes a shelf life that has not been validated. This poses a risk to patients relying on the device's effectiveness and safety.
No specific incidents or injuries have been reported in connection with this recall. However, the potential for ineffective medical devices raises serious concerns.
Stop using the distraction pins immediately. Follow the recall instructions provided by the manufacturer and contact Folsom Metal Products, Inc. or your healthcare provider for further guidance.
For more information, contact Folsom Metal Products, Inc. at the phone number listed on their website or through the provided recall notification.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.